Clinical Trials Browser

Phase 3 × Interventional × Atorvastatin × Clear all

Prostatic Neoplasms

NCT04026230 2022-10-21

ESTO2

Phase 3 Unknown

400 enrolled

Genitourinary

Prostatic Neoplasms

NCT02201381 2022-07-18

METRICS

Phase 3 Withdrawn

BreastCNSGastrointestinalGynecologic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Phase 3 Withdrawn

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Phase 3 Recruiting

3,360 enrolled

Breast

Breast Neoplasms

Clinical Trials

PEACE-4

ESTO2

METRICS

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

The MASTER Study (MAmmary Cancer STatin ER Positive Study)